In a major strategic move, Eli Lilly and Company (NYSE: LLY) has announced a definitive agreement to acquire Morphic Holding, Inc. (NASDAQ: MORF), a biopharmaceutical company known for its innovative work in developing oral integrin therapies. The acquisition, valued at $57 per share in cash, totals approximately $3.2 billion. This acquisition represents a significant premium […]
Novo Nordisk, a global leader in pharmaceutical manufacturing, has unveiled plans to invest $4.1 billion (approximately 27 billion Danish kroner) to establish a second fill and finishing manufacturing facility in Clayton, North Carolina. This initiative marks one of the largest manufacturing investments in the company’s history and aims to significantly enhance its capacity to produce […]
